# To Study Safety, Tolerability and Pharmacokinetics of AZD1305 in Healthy Male Japanese Subjects

> **NCT00738322** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 36 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AZD1305
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00738322
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** —
- **Final completion:** 2008-10
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2009-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00738322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00738322, "To Study Safety, Tolerability and Pharmacokinetics of AZD1305 in Healthy Male Japanese Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00738322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*